Which vasodilator patch is used in adult cardiogenic shock?

Which vasodilator patch is used in adult cardiogenic shock?

• A. Nitro-Paste: 1\" to the anterior upper chest
• B. Nitroglycerin IV drip
• C. Isosorbide dinitrate tablet
• D. Placebo patch

Answer: (A)

In managing adult cardiogenic shock, the goal of vasodilator therapy is to reduce the heart’s workload by lowering preload and afterload so the failing ventricle can push blood forward more effectively, while carefully avoiding dangerous drops in blood pressure. A transdermal nitroglycerin patch delivers a steady, controlled amount of nitroglycerin, producing gradual venodilation with some arterial effect, which lowers filling pressures and systemic resistance without the need for continuous IV access. This steady delivery is particularly useful when you want ongoing vasodilation with predictable absorption, and it’s applied to the anterior upper chest to ensure consistent dosing. In contrast, an IV nitro drip provides rapid, titratable control; an oral isosorbide dinitrate tablet isn’t a patch and is less suitable for acute, controlled vasodilation; and a placebo patch has no therapeutic effect. Therefore, the patch form of nitroglycerin is the appropriate choice.

In managing adult cardiogenic shock, the goal of vasodilator therapy is to reduce the heart’s workload by lowering preload and afterload so the failing ventricle can push blood forward more effectively, while carefully avoiding dangerous drops in blood pressure. A transdermal nitroglycerin patch delivers a steady, controlled amount of nitroglycerin, producing gradual venodilation with some arterial effect, which lowers filling pressures and systemic resistance without the need for continuous IV access. This steady delivery is particularly useful when you want ongoing vasodilation with predictable absorption, and it’s applied to the anterior upper chest to ensure consistent dosing. In contrast, an IV nitro drip provides rapid, titratable control; an oral isosorbide dinitrate tablet isn’t a patch and is less suitable for acute, controlled vasodilation; and a placebo patch has no therapeutic effect. Therefore, the patch form of nitroglycerin is the appropriate choice.